期刊文献+

Caco-2细胞模型在口服药物吸收研究中的应用 被引量:38

Important application of Caco-2 cell monolayers in the study of the intestinal oral absorption
下载PDF
导出
摘要 目的对Caco-2细胞模型在口服药物肠吸收研究中的应用作一综述.方法在引用了自1974~2004年的32篇文献的基础上,通过介绍并比较体外Caco-2模型和体内药物吸收转运的不同途径,讨论Caco-2单层细胞模型在预测不同类药物体内吸收中的作用.结果 Caco-2细胞模型可以预测不同转运途径的药物体内吸收,尤其适用于被动转运药物,这一细胞模型在药物吸收机制、处方组成透膜性和黏膜毒性、药物吸收过程中的相互作用、药物的化学结构和体内转运关系、药物吸收限速因素、药物代谢稳定性及pH对药物吸收的影响等研究中均有较广泛的应用.结论 Caco-2细胞模型用于预测各种途径的药物吸收,在细胞水平上提供了大量与吸收相关的信息,是口服药物高通量筛选的良好工具. Objective To review the important applications of Caco-2 cell monolayers in the study of the intestinal absorption of oral drug. Methods Based on 32 papers published from 1974 to 2004, the different routes of drug transport in Caco-2 cell monolayers are compared with those seen in vivo and the prediction of drug absorption in vivo from transport experiments in cell monolayers is discussed for different classes of drug. Results Caco-2 cell monolayers model could predict the absorption of drugs transported by different routes, especially for the passive transport drugs, this cell model was applied extensively in the study of the mechanism of absorption, permeability and toxity to mucous membrane of drug formulation component, interactions between drugs in the process of absorption, relationship between the chemical structures and transport in vivo, restricted step of absorption, metabolism of drugs and the effect of pH on the absorption. Conclusions Caco-2 cell monolayers model can predict the absorption of drugs transported by different routes and provide a large amount of information related to the drug absorption. It can be used as effective tool for oral drug high-throughput screening.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2005年第6期469-474,共6页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目(30400563)
关键词 药物转运 药物吸收 CACO-2 单细胞层 drug transport drug absorption Caco-2 cell monolayers
  • 相关文献

参考文献32

  • 1杨海涛,王广基.Caco-2单层细胞模型及其在药学中的应用[J].药学学报,2000,35(10):797-800. 被引量:58
  • 2Pappenheimer J R, Reiss K Z. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat[J] .J Membr Bio, 1987, 100(2):123 - 136.
  • 3Nellan H N. Paracellular intestinal transport: modulation of absorption[J]. Adv Drug Deliv Rev, 1991, 7(3):339 - 364.
  • 4Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junction[J]. J Cell Bio, 1993, 123(6 Pt 2):1777 - 1788.
  • 5Lennernas H, Nilsson D, Aquilonius S M, et al. The effect of L-leucin on the absorption of levodopa, studied by regional jejeunal perfusion in man[J]. Br J Clin Pharmacol, 1993, 35(3):243 - 250.
  • 6Phung-Ba V, Warnery A, Scherman D, et al. Interaction of pristinamycin IA with P-glycoprotein in human intestinal epithelial cells[J]. Eur J Pharmacol, 1995,288(2): 187 - 192.
  • 7Hunter J, Jepson M A, Tsuruo T, et al. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells[J]. J Biol Chem, 1993,268(20): 14991 - 14997.
  • 8de Aizpurua H J, Russel-Jones G J. Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding[J]. J Exp Med,1988, 167(2):440 - 451.
  • 9Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2)cells[J]. Biochem Biophys Res Commun, 1991, 175(3):880 - 885.
  • 10Wils P, Warnery A, Phung-Ba V, et al. Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs[J]. Cell Biol Toxicol, 1994, 10(5-6) :393-397.

二级参考文献13

  • 1陈纪岳,胡明,朱彦平.药物从人小肠上皮细胞模型排放的动力学模型[J].上海医科大学学报,1996,23(4):247-251. 被引量:8
  • 2[1]Pantazis P, Earuj JA, Kozielski AJ, et al. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro [J]. Cancer Res, 1993,53(7) :1577 - 1582.
  • 3[2]Sands H, Mishra A, Stoeckler JD, et al. Preclinical activity of an iv formulation of rubitecan in IDD-PTM against human solid tumor xenografts [ J ]. Anticancer Drugs, 2002,13 (9): 965 - 975.
  • 4[3]Zhong DF, Li K, Xu JH, et al. Pharmacokinetics of 9-nitro-20 (S) -camptothecin in rats [ J ]. Acta Pharmacol Sin, 2003,24 (3) :256 - 262.
  • 5[4]Creemers GJ, Gervits CJH, Eckhardt J. Phase Ⅰ and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors [J].J Clin Oncol, 1997,15(3) :1087 - 1090.
  • 6[5]Chu XY, Suzuki H, Ueda K, et al. Active efflux of CPT-11 and its metabolites in human KB-derived cell lines[J]. J Pharmacol Exp Ther , 1999,288(2) :735 -741.
  • 7[6]Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport[J]. Adv DrugDeliv Rev, 2001,46(1 -3):27 -43.
  • 8[7]Hu M, Chen J, Zhu Y, et al. Mechanism and kinetics of transcellular transport of a new lactam antibiotic loracarbef across an human intestinal epithelial model system (Caco-2) [J]. PharmRes, 1994,11(12):1405-1413.
  • 9[8]Monkkonen H, Tormalehto S, Asunmaa K, et al.Cellular uptake and metabolism of clodronate and its derivatives in Caco-2 cells: a possible correlation with bisphosphonate-induced gastrointestinal side-effects [J].Eur J Pharm Sci, 2003,19( 1 ) :23 -29.
  • 10[9]Warner DL, Burke TG. Simple and versatile highperformance liquid chromatographic method for the simultaneous quantity of the lactone and carboxylate forms of camptothecin anticancer drugs [ J ]. J Chromatogr B Biomed Appl, 1997,691 ( 1 ): 161 - 171.

共引文献74

同被引文献422

引证文献38

二级引证文献206

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部